Seizure, Journal Year: 2023, Volume and Issue: 112, P. 98 - 105
Published: Sept. 26, 2023
Language: Английский
Seizure, Journal Year: 2023, Volume and Issue: 112, P. 98 - 105
Published: Sept. 26, 2023
Language: Английский
The Lancet, Journal Year: 2023, Volume and Issue: 402(10399), P. 412 - 424
Published: July 1, 2023
Language: Английский
Citations
107Neurotherapeutics, Journal Year: 2024, Volume and Issue: 21(3), P. e00308 - e00308
Published: Jan. 4, 2024
Epilepsy is a common and debilitating neurological disorder, approximately one-third of affected individuals have ongoing seizures despite appropriate trials two anti-seizure medications. This population with drug-resistant epilepsy (DRE) may benefit from neurostimulation approaches, such as vagus nerve stimulation (VNS), deep brain (DBS) responsive (RNS). In some patient populations, these techniques are FDA-approved for treating DRE. VNS used adjuvant therapy children adults. Acting via the afferent network, modulates thalamocortical circuits, reducing in 50 % patients. RNS uses an adaptive (closed-loop) system that records intracranial EEG patterns to activate at time, being particularly well-suited treat arising within eloquent cortex. For DBS, most promising therapeutic targets anterior centromedian nuclei thalamus, nucleus DBS focal secondarily generalized forms DRE applied epilepsies Lennox-Gastaut syndrome. Here, we discuss indications, advantages limitations VNS, summarize spatial distribution neuroimaging observations related using NeuroQuery NeuroSynth.
Language: Английский
Citations
21Epilepsy & Behavior, Journal Year: 2023, Volume and Issue: 142, P. 109182 - 109182
Published: March 25, 2023
Language: Английский
Citations
24Nature Neuroscience, Journal Year: 2024, Volume and Issue: unknown
Published: Nov. 15, 2024
Language: Английский
Citations
8JAMA Neurology, Journal Year: 2024, Volume and Issue: 81(5), P. 499 - 499
Published: April 1, 2024
Interdisciplinary practice parameters recommend that patients with drug-resistant epilepsy (DRE) undergo comprehensive neurodiagnostic evaluation, including presurgical assessment. Reporting from specialized centers suggests long delays to referral and underuse of surgery; however, longitudinal data are limited characterize evaluation among DRE in more diverse US settings populations.
Language: Английский
Citations
7Biomedical Physics & Engineering Express, Journal Year: 2024, Volume and Issue: 10(2), P. 025041 - 025041
Published: Feb. 15, 2024
One of the epileptic patients' challenges is to detect time seizures and possibility predicting. This research aims provide an algorithm based on deep learning predict seizure from one two minutes before its occurrence. The proposed Convolutional Neural Network (CNN) can occurrence focal epilepsy through single-lead-ECG signal processing instead using EEG signals. structure CNN for detection prediction same. Considering requirements a wearable system, after few light pre-processing steps, ECG be used as input neural network without any manual feature extraction step. desired learns purposeful features according labelled signals then performs classification these Training 39-layer has been done separately. method with accuracy 98.84% them 94.29%. With this approach, promising indicator construction portable systems monitoring status patients.
Language: Английский
Citations
5Expert Opinion on Biological Therapy, Journal Year: 2024, Volume and Issue: 24(8), P. 773 - 785
Published: July 27, 2024
In gene therapy with adeno-associated virus (AAV) vectors for diseases of the central nervous system, can be administered into blood vessels, cerebrospinal fluid space, or brain parenchyma. When transfer to a large area is required, first two methods are used, but in which local expected effective, directly
Language: Английский
Citations
5CNS Neuroscience & Therapeutics, Journal Year: 2025, Volume and Issue: 31(2)
Published: Feb. 1, 2025
The limited efficacy and very restricted antiseizure range of current deep brain stimulation (DBS) targets highlight the need to find an optimal target for managing various seizure types. Here, we aimed investigate DBS on ventromedial hypothalamus (VMH) in different types experimental epileptic seizures. was examined models, potential mechanisms were investigated by using vivo calcium signal recording optogenetics. c-fos expression significantly increased glutamatergic neurons VMH (VMHglu) following Then, 1-Hz low-frequency (LFS) at successfully attenuated severities across models epilepsy, including maximal electroshock, pentylenetetrazol, absence seizure, cortical or hippocampal kainic acid-induced acute hippocampal-kindling models. imaging recordings revealed that LFS could inhibit activities VMHglu. Optogenetic inhibition VMHglu mirrored LFS's impact. Further anterograde viral tracing confirmed extensive distributed projections VMHglu, which may compose circuitry basis broad-spectral LFS. These findings demonstrate VMH-LFS is a broad-spectrum treatment approach decreasing activity.
Language: Английский
Citations
0Journal of Integrative Neuroscience, Journal Year: 2025, Volume and Issue: 24(2)
Published: Feb. 20, 2025
Neuroregulatory therapy, encompassing deep brain stimulation and responsive neurostimulation, is increasingly gaining attention for the treatment of drug-resistant temporal occipital lobe epilepsy. Beyond approved anterior nucleus thalamus, pulvinar thalamus a potential target. Through confluence animal studies, electrophysiological research, imaging has been identified as having extensive connections with visual cortex, prefrontal limbic regions, multimodal sensory associative areas, playing pivotal role in multisensory integration serving propagation node both generalized focal This review synthesizes recent research on relation to cortical epileptic networks, well efficacy neuroregulatory therapy targeting Further warranted elucidate differential therapeutic effects stimulating various subregions specific mechanisms underlying epilepsy through stimulation.
Language: Английский
Citations
0Journal of Clinical Neurology, Journal Year: 2025, Volume and Issue: 21(2), P. 113 - 113
Published: Jan. 1, 2025
There is a current need to understand the efficacy and quality of life (QoL) outcomes vagus nerve stimulation (VNS). Identifying patients most likely benefit from VNS could aid in their selection, reduce side effects, improve outcomes. Here we studied clinical QoL after with drug-resistant epilepsy attempted identify response predictors. This was retrospective study 55 treated surgically during 2004-2018, 40 whom were eligible for inclusion analysis. All surgeries performed using standard protocol by neurosurgeon experienced treatment referral an attending neurologist. Data collected medical records through 28-item questionnaire on seizure frequency, duration, strength before VNS, as number type postoperative complications significance patient, based 31-item Quality Life Epilepsy questionnaire. Improvements observed 65% VNS. The common complication hoarseness (70%), poorly tolerated 12% patients. Repeated surgery replace batteries or electrodes required 20% Health status only parameter significantly impacted No significant predictors identified. Efficacy across first month strong indicator long-term stimulator can be removed if it does not provide any benefit.
Language: Английский
Citations
0